申请人:John Wyeth & Brother Limited
公开号:US04046895A1
公开(公告)日:1977-09-06
The invention provides a compound of formula I ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and represent hydrogen or alkyl of 1-6 carbon atoms, R.sup.3 represents hydrogen, alkyl of 1-6 carbon atoms, or phenyl, X is Na, K, Li, or CSNHR.sup.4 wherein R.sup.4 is hydrogen or alkyl of 1-6 carbon atoms and n is 3, 4 or 5 or a pharmaceutically acceptacle acid addition salt of a compound where X is CSNHR.sup.4. The compounds of formula I wherein X is CSNHR.sup.4 are anti-ulcer agents. Those in which X is Na, K or Li are intermediates.
该发明提供了一种式I的化合物,其中R.sup.1和R.sup.2相同或不同,代表1-6个碳原子的氢或烷基,R.sup.3代表氢、1-6个碳原子的烷基或苯基,X为Na、K、Li或CSNHR.sup.4,其中R.sup.4为氢或1-6个碳原子的烷基,n为3、4或5,或者X为CSNHR.sup.4时的化合物的药学接受酸盐。其中X为CSNHR.sup.4时的式I化合物为抗溃疡剂。其中X为Na、K或Li时为中间体。